Trial Profile

A Randomized, Open-Label, Comparative, Parallel-Group, Multicenter Study of SPARC1507 in Subjects With Cancer

Status: Withdrawn prior to enrolment

Phase of Trial: Phase III

Latest Information Update: 16 Dec 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Paclitaxel (Primary)
Indications Biliary cancer; Carcinoma
Focus Registrational; Therapeutic Use
Sponsors Sun Pharma Advanced Research Company

Most Recent Events

10 Dec 2020 Status changed from not yet recruiting to withdrawn prior to enrolment.
13 Nov 2018 Planned initiation date changed from 1 Dec 2016 to 1 Dec 2018.
13 Nov 2018 Planned primary completion date changed from 1 Dec 2019 to 1 Mar 2019.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com